期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Botulinum toxin and benign prostatic hyperplasia 被引量:2
1
作者 lay guat ng 《Asian Journal of Urology》 2018年第1期33-36,共4页
Benign prostatic hyperplasia(BPH)is a clinical condition where lower urinary tract symptoms are caused by both a physically obstructing prostate as well as tight smooth muscles around the bladder outlet.Treatment of t... Benign prostatic hyperplasia(BPH)is a clinical condition where lower urinary tract symptoms are caused by both a physically obstructing prostate as well as tight smooth muscles around the bladder outlet.Treatment of this condition with botulinum toxin has been used since 2003,but this interest has somewhat died down after two large randomized controlled trials(RCTs)showing equivalence of results between their treatment and placebo arms.However,with review of animal studies and unexplained exaggerated effect of the placebo arms of the two RCTs,together with recent data of sustained benefits after 18 months of treatment,the place of botulinum toxin in the BPH field is probably still present. 展开更多
关键词 Benign prostatic hyperplasia Botulinum toxin Bladder outlet obstruction
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部